Preferred Name | rifapentine | |
Synonyms |
DL 473-IT DL 473 DL-4-73 Priftin 3-(((4-cyclopentyl-1-piperazinyl)imino)methyl)rifamycin SV 3-(((4-cyclopentyl-1-piperazinyl)imino)methyl)rifamycin MDL 473 Rifapex |
|
ID |
http://purl.bioontology.org/ontology/MESH/C018421 |
|
altLabel |
DL 473-IT DL 473 DL-4-73 Priftin 3-(((4-cyclopentyl-1-piperazinyl)imino)methyl)rifamycin SV 3-(((4-cyclopentyl-1-piperazinyl)imino)methyl)rifamycin MDL 473 Rifapex |
|
cui |
C0073372 C0127260 C2713402 C0114430 C0876758 C0283271 |
|
Has mapping qualifier | ||
HM |
D012293/Q000031 |
|
Inverse of RB |
XJM390A33U 0 |
|
isa | ||
LT |
TRD |
|
Mapped to | ||
MDA |
19790101 |
|
MeSH Frequency |
387 |
|
MMR |
20150927 |
|
notation |
C018421 |
|
PA |
D000904 D007917 |
|
PI |
CYCLOPENTANES (79-81) |
|
prefLabel |
rifapentine |
|
RR |
61379-65-5 (rifapentine) |
|
SC |
1 |
|
Scope Statement |
cyclopentyl derivative of rifampicin |
|
SRC |
Br J Clin Pharm 6(5):455P;1978 |
|
TERMUI |
T099931 T099929 T754777 T099925 T099928 T099930 T461372 T099927 T099926 |
|
TH |
US NLM (1979) NLM (2009) INN (19XX) FDA SRS (2015) USAN (1984) |
|
tui |
T109 T195 |
Create mapping